FDA Drug Application (088052) for SULFASALAZINE by WATSON LABS

Back to FDA Applications sponsored by WATSON LABS

Application Number088052
Product Number001
FormTABLET, DELAYED RELEASE;ORAL
Dosage500MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSULFASALAZINE
Active IngredientSULFASALAZINE

Active IngredientCount
List of drugs with Active Ingredient SULFASALAZINE4


Back to FDA Applications sponsored by WATSON LABS